PCN67 COST-UTILITY OF KRAS MUTATION TESTING PRIOR TO TREATMENT OF METASTATIC COLORECTAL CANCER WITH CETUXIMAB MONOTHERAPY
May 1, 2010, 00:00 AM
10.1016/S1098-3015(10)72156-2
https://www.valueinhealthjournal.com/article/S1098-3015(10)72156-2/fulltext
Section Title :
Section Order :
738
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)72156-2&doi=10.1016/S1098-3015(10)72156-2